Copyright
©The Author(s) 2025.
World J Clin Oncol. Apr 24, 2025; 16(4): 104827
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.104827
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.104827
Table 5 Reported side effects during the entire study period
Side effect | Number of patients | Percentage of total patients (%) |
Dizziness | 5 | 50 |
Drowsiness | 4 | 40 |
Weight gain | 3 | 30 |
Dry mouth | 2 | 20 |
- Citation: Chakraborty P, Borgohain M. Evaluating pregabalin in cancer patients with chronic neuropathic pain and depression: an observational case series. World J Clin Oncol 2025; 16(4): 104827
- URL: https://www.wjgnet.com/2218-4333/full/v16/i4/104827.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i4.104827